CXCL9 and ovarian cancer: The same is true for ovarian cancer, favorable radiomics applications in OC like early diagnosis, subtype classification, treatment response prediction, lymph node metastasis, and survival [29–32], raised the possibility of radiomics uncovering the CXCL9 status in OC patients.Therefore, we aimed to apply radiomics to the prediction of OC survival using CT features extracted from pretreatment images of primary tumors.